儿童侵袭性肺炎球菌病在 COVID-19 大流行期间减少。
Decrease in Pediatric Invasive Pneumococcal Disease During the COVID-19 Pandemic.
机构信息
Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
Department of Pediatrics, Nationwide Children's Hospital and College of Medicine and Public Health, The Ohio State University, Columbus, Ohio, USA.
出版信息
J Pediatric Infect Dis Soc. 2022 Sep 29;11(9):426-428. doi: 10.1093/jpids/piac056.
Abstract
Measures to limit SARS-CoV-2 transmission in 2020 reduced other viral infections. Among 7 US children's hospitals, invasive pneumococcal disease cumulative incidence decreased by 46% in 2020 vs 2017-2019. Limited droplet transmission of pneumococci and preceding viral pathogens may be responsible.
摘要
2020 年为限制 SARS-CoV-2 传播而采取的措施减少了其他病毒感染。在美国 7 家儿童医院中，2020 年侵袭性肺炎球菌病累计发病率较 2017-2019 年下降了 46%。肺炎球菌和先前的病毒病原体的有限飞沫传播可能是造成这一现象的原因。
相似文献
1
Decrease in Pediatric Invasive Pneumococcal Disease During the COVID-19 Pandemic.
J Pediatric Infect Dis Soc. 2022 Sep 29;11(9):426-428. doi: 10.1093/jpids/piac056.
2
Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England.
Emerg Infect Dis. 2022 Aug;28(8):1669-1672. doi: 10.3201/eid2808.220304.
3
Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
JAMA Netw Open. 2022 Jun 1;5(6):e2218959. doi: 10.1001/jamanetworkopen.2022.18959.
4
The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy).
Infection. 2022 Jun;50(3):767-770. doi: 10.1007/s15010-022-01770-6. Epub 2022 Feb 16.
5
Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implementation of non-pharmaceutical interventions during COVID-19 pandemic.
Eur Respir J. 2021 Nov 4;58(5). doi: 10.1183/13993003.00978-2021. Print 2021 Oct.
6
Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan.
J Infect. 2021 Feb;82(2):282-327. doi: 10.1016/j.jinf.2020.09.018. Epub 2020 Sep 19.
7
Substantial Decline in Invasive Pneumococcal Disease During Coronavirus Disease 2019 Pandemic in Hong Kong.
Clin Infect Dis. 2022 Jan 29;74(2):335-338. doi: 10.1093/cid/ciab382.
8
The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
Int J Infect Dis. 2021 Oct;111:196-203. doi: 10.1016/j.ijid.2021.08.060. Epub 2021 Aug 26.
9
The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan.
Hum Vaccin Immunother. 2021 Nov 2;17(11):4673-4674. doi: 10.1080/21645515.2021.1958612. Epub 2021 Aug 6.
10
Infant Pneumococcal Carriage in Belgium Not Affected by COVID-19 Containment Measures.
Front Cell Infect Microbiol. 2022 Jan 17;11:825427. doi: 10.3389/fcimb.2021.825427. eCollection 2021.
引用本文的文献
1
Hospital burden of pneumococcal disease in Spain (2016-2022): A retrospective study.
Hum Vaccin Immunother. 2025 Dec;21(1):2437915. doi: 10.1080/21645515.2024.2437915. Epub 2025 Jan 9.
2
Serotype distribution, clinical characteristics, and antimicrobial resistance of pediatric invasive pneumococcal disease in Colombia during PCV10 mass vaccination (2017-2022).
Front Med (Lausanne). 2024 May 22;11:1380125. doi: 10.3389/fmed.2024.1380125. eCollection 2024.
3
Increase in complicated upper respiratory tract infection in children during the 2022/2023 winter season-a post coronavirus disease 2019 effect?
Pediatr Radiol. 2024 Jan;54(1):49-57. doi: 10.1007/s00247-023-05808-1. Epub 2023 Nov 24.
4
Changes in the Incidence of Invasive Pneumococcal Disease in Calgary, Canada, during the SARS-CoV-2 Pandemic 2020-2022.
Microorganisms. 2023 May 18;11(5):1333. doi: 10.3390/microorganisms11051333.
5
Burden of Hospitalizations Related to Pneumococcal Infection in Spain (2016-2020).
Antibiotics (Basel). 2023 Jan 14;12(1):172. doi: 10.3390/antibiotics12010172.
Zotero 插件